Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Debu, Tripathy"'
Autor:
Jennifer K. Litton, Bora Lim, Rosalind P. Candelaria, Rachel M. Layman, Alastair M. Thompson, William Fraser Symmans, Debu Tripathy, Senthil Damodaran, Lei Huo, Rashmi Krishna Murthy, Vicente Valero, Jianjun Zhang, Naoto T. Ueno, Banu Arun, Gaiane M. Rauch, Qingqing Ding, Stacy L. Moulder, Li Zhao, Sahil Seth, Jason B White
Publikováno v:
Journal of Clinical Oncology. 38:517-517
517 Background: The luminal androgen receptor (LAR) subtype of TNBC has a low pathologic complete response (pCR) rate after NAT. We determined the pCR rate of the enzalutamide and paclitaxel (ZT) regimen for pts with anthracycline-insensitive AR+ TNB
Autor:
Naoto T. Ueno, Jie Willey, Rashmi Krishna Murthy, Ricardo H. Alvarez, S. Jackson, Debu Tripathy, Sharon H. Giordano, Stacy L. Moulder, Carlos H. Barcenas, Abenaa M. Brewster, Nuhad K. Ibrahim, Vicente Valero, Ronald S. Walters, Daniel J. Booser, Powel H. Brown, Jangsoon Lee, Meghan Sri Karuturi, Bora Lim
Publikováno v:
Journal of Clinical Oncology. 34:609-609
609Background: Entinostat (E) an HDAC inhibitor, and Lapatinib (L) given in combination induces FOXO3a and mediates Bim1 expression in HER2+ cell lines resulting in apoptosis [Lee et al. BCRT 2014]...
Autor:
Hope S. Rugo, Diana Lake, Constance Cirrincione, Mary Ellen Moynahan, Maura N. Dickler, Eric P. Winer, Debu Tripathy, Arti Hurria, Clifford A. Hudis, William T. Barry, Bryan P. Schneider, Federico Innocenti, Olwen Hahn, Matthew J. Ellis
Publikováno v:
Journal of Clinical Oncology. 33:501-501
501 Background: Preclinical data suggest estradiol modulates angiogenesis under both physiologic and pathologic conditions. High vascular endothelial growth factor (VEGF) levels in breast tumors ha...
Autor:
Cheryl Ewing, Rita Nanda, Debu Tripathy, Laura van 't Veer, Angela DeMichele, Henry G. Kaplan, Anne M. Wallace, Laura J. Esserman, Kathy S. Albain, Amy Jo Chien, Stacy L. Moulder, William Fraser Symmans, Douglas Yee, Meredith Buxton, Nola M. Hylton, Donald A. Berry, Melissa Paoloni, Barbara Haley, Andres Forero
Publikováno v:
Journal of Clinical Oncology. 33:524-524
524 Background: A key node of growth and survival signaling pathways is the Akt serine/threonine kinase that activates mTOR and downstream effectors. I-SPY 2 is a randomized neoadjuvant trial to te...
Autor:
Debu Tripathy, Traci L. Kalberer, Claudio Faria, Nancy L. Beegle, George Dranitsaris, John David Cox
Publikováno v:
Journal of Clinical Oncology. 31:174-174
174 Background: There have been important advances in the treatment of patients with MBC. However, certain patient subgroups such as whose who are triple negative remain a therapeutic challenge. Eribulin is the newest cytotoxic to gain regulatory app